Back to News
investment
Bayer Sees Flat 2026 Profits Amid Roundup Settlement Efforts
Sonja Wind
Loading...
1 min read
0 likes
Quantum News · Media Library
Understand this faster with AI
Bayer AG forecast little change in profit and sales in 2026 as the German agriculture and health company grapples with generic competition for its blockbuster blood thinner and continued uncertainty over its efforts to contain a pesticide litigation in the US.
Source Information
Source: Bloomberg
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.